Legence Corp. (LGN)
NASDAQ: LGN · Real-Time Price · USD
53.57
-0.28 (-0.52%)
Aug 31, 2026, 4:00 PM EDT - Market closed

Legence Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24
1,2621,038737.64708.01598.89505.95548.22560.8520.79468.8
Revenue Growth (YoY)
110.74%105.14%34.55%26.25%15.00%7.93%----
Cost of Revenue
1,042851.74590.15559.95470.22394.25435.27442.26407.99382.31
Gross Profit
220.23186.15147.49148.06128.67111.7112.94118.55112.7986.49
Selling, General & Admin
147.59115.8114.0285.4972.1768.1660.9966.557.3854.57
Operating Expenses
185.56152.62138.76109.6797.5194.2587.4191.9780.8176.41
Operating Income
34.6733.538.7338.3931.1617.4525.5326.5731.9910.08
Interest Expense
-16.91-17-13.55-28.18-30.4-29.64-26.22-23.71-20.82-20.87
Interest & Investment Income
1.911.321.91.070.760.761.110.521.72.14
Earnings From Equity Investments
0.090.50.60.020.360.46-0.071.230.861.04
Other Non Operating Income (Expenses)
-1.850.57-10.060.06-0.010.11-3.640.12-1.80.29
EBT Excluding Unusual Items
17.9118.92-12.3911.361.87-10.87-3.294.7411.93-7.32
Merger & Restructuring Charges
-0.42-11.73-5.57-1.2-0.32-1.46-2.09-0.85-2.08-4.06
Impairment of Goodwill
-21.59--24.97----17.8---
Gain (Loss) on Sale of Assets
0.120.060.13-0.020.120.1----
Asset Writedown
-19.49--2.42-------
Other Unusual Items
-0.01-3.24-0.97-5.69--2.88----2.3
Pretax Income
-23.474.01-46.184.461.68-15.1-23.183.899.85-13.68
Income Tax Expense
11.09-13.388.54.085.554.04-4.984.563.661.28
Earnings From Continuing Operations
-34.5617.39-54.670.38-3.87-19.14-18.2-0.686.19-14.96
Minority Interest in Earnings
6.72-1.321.95-0.96-1.4-2.07-0.51-0.41--
Net Income
-27.8416.09-32.72-0.58-5.27-21.21-18.71-1.086.19-14.96
Preferred Dividends & Other Adjustments
---0.5------
Net Income to Common
-27.8416.09-32.72-1.08-5.27-21.21-18.71-1.086.19-14.96
Net Income Growth (YoY)
----------
Shares Outstanding (Basic)
7667605959-----
Shares Outstanding (Diluted)
76108605959-----
Shares Change (YoY)
29.95%---------
EPS (Basic)
-0.370.24-0.55-0.02-0.09-----
EPS (Diluted)
-0.370.13-0.55-0.02-0.09-----
EPS Growth (YoY)
----------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24
Free Cash Flow
50.34102.2981.5489.0124.2824.1-0.1936.83-55.7929.41
Free Cash Flow Per Share
0.660.941.371.520.41-----
Gross Margin
17.45%17.94%19.99%20.91%21.49%22.08%20.60%21.14%21.66%18.45%
Operating Margin
2.75%3.23%1.18%5.42%5.20%3.45%4.66%4.74%6.14%2.15%
Profit Margin
-2.21%1.55%-4.44%-0.15%-0.88%-4.19%-3.41%-0.19%1.19%-3.19%
Free Cash Flow Margin
3.99%9.86%11.05%12.57%4.05%4.76%-0.03%6.57%-10.71%6.27%
EBITDA
78.8675.8137.465.8859.9346.855.455.2458.8235.57
EBITDA Margin
6.25%7.30%5.07%9.30%10.01%9.25%10.11%9.85%11.29%7.59%
D&A For EBITDA
44.1942.2828.6827.4928.7729.3529.8628.6726.8325.49
EBIT
34.6733.538.7338.3931.1617.4525.5326.5731.9910.08
EBIT Margin
2.75%3.23%1.18%5.42%5.20%3.45%4.66%4.74%6.14%2.15%
Effective Tax Rate
---91.50%330.71%--117.39%37.13%-
SEC Filings: 10-K · 10-Q